Chemical Engineering Spring Seminar Series: Dr. Christina Chan

103 Churchill 103 Churchill Hall, 360 Huntington Ave, Boston, MA, United States

Our group incorporates metabolic engineering and systems biology approaches in combination with biochemical and molecular biology measurements to identify targets and disease biomarkers. To modulate these targets and pathway we are concomitantly developing polymeric-based drug delivery systems.

Chemical Engineering Spring Seminar Series: Dr. Sindia M. Rivera Jiménez

103 Churchill 103 Churchill Hall, 360 Huntington Ave, Boston, MA, United States

Professional organizations (POs) are established communities that significantly influence the competencies and values of engineers, but the impact of their interaction with academia on undergraduate education is not fully understood.

Recurring

Soft Matter Days

Soft Matter Days: April 8-17, will feature invited guest speakers discussing a variety of interdisciplinary topics in soft matter and complex fluids.  These topics sit at the interface of chemical […]

Recurring

Soft Matter Days

Soft Matter Days: April 8-17, will feature invited guest speakers discussing a variety of interdisciplinary topics in soft matter and complex fluids.  These topics sit at the interface of chemical […]

Recurring

Soft Matter Days

Soft Matter Days: April 8-17, will feature invited guest speakers discussing a variety of interdisciplinary topics in soft matter and complex fluids.  These topics sit at the interface of chemical […]

Recurring

Soft Matter Days

Soft Matter Days: April 8-17, will feature invited guest speakers discussing a variety of interdisciplinary topics in soft matter and complex fluids.  These topics sit at the interface of chemical […]

Recurring

Soft Matter Days

Soft Matter Days: April 8-17, will feature invited guest speakers discussing a variety of interdisciplinary topics in soft matter and complex fluids.  These topics sit at the interface of chemical […]

ChE PhD Dissertation Defense: Ian Smith

Development of an in vitro-in vivo correlation between lymph-cannulated animals and the primary transport assay developed herein might assist preclinical programs in translating lipid-based oral modalities to humans. Expansion of the organoid donor set (by species and small intestinal region), combinatorial probing of more lipid stimulation axes (by substrate chain length and saturation), and scaling of monolayer culture could refine the lymphatic assay into a high-throughput screen.